pSivida Corp - PSDV - reported the positive outcome of the Decentralized Procedure for the approval of ILUVIEN in Europe. JA Solar Holdings Co. Ltd - JASO - announced that shipments for the Q4 of 2011 are expected to be in the range of 390 to 410 megawatts, exceeding the Company's previously provided shipment guidance of 310 to 330 megawatts. Coronado Biosciences Inc - CNDO - reported positive results from the Phase 1 clinical trial of TSO (Trichuris suis ova or CNDO-201) in patients with Crohn's disease. According to the company, the study showed that TSO is safe and well tolerated ***** THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY! (Read Full Disclaimer at http://www.crwenewswire.com/disclaimer)

• Added by: karmastock
• Date added: 28/02/12
• Video Duration: 01:14
• Category: News
• Number of views:314
• Tags: ILUVIEN, Crohn disease, pSivida, JA Solar, Coronado Biosciences, PSDV, JASO, CNDO, Nasdaq:PSDV, Nasdaq:JASO, Nasdaq:CNDO (PSDV, CNDO, JASO) CRWENewswire Stocks In Action



Post a Comment

To add a comment, please fill out the box below and click on the submit button. Comment:

There are currently no comments for this video